News

Biosfer Teslab in the newspaper la Vanguardia

News about Biosfer Teslab appeared in the reportage of the la Vanguardia newspaper, 25 of October, 2015, it’s title was “Un test més efectiu per al ‘colesterol dolent’” that means “A more efective test for the ‘bad cholesterol’” More information here.

Open call to join our operations team

Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for candidates to join our operations team. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i… Read More »Open call to join our operations team

Open call for an Industrial Doctorate

Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for Industrial Doctorate candidates. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i Virgili University and… Read More »Open call for an Industrial Doctorate

Practical Applications of NMR in Industry Conference (PANIC) – Feb 2015 La Jolla, CA

Roger Mallol will give a talk in the 3rd Annual Practical Applications of NMR in Industry Conference (PANIC) that will take place in La Jolla, CA, February 9-12, 2015. PANIC was initiated to provide an interactive forum for discussion of the latest developments in the use of NMR for practical applications to real problems faced… Read More »Practical Applications of NMR in Industry Conference (PANIC) – Feb 2015 La Jolla, CA

Call for an Industrial Doctoral Student

Biosfer Teslab is seeking candidates for an industrial doctorate to develop NMR-based in vitro diagnostic tests for cardiovascular risk assessment. Further information about the call can be found here.

Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course

Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course to be held on 25th – 27th of September in Bruges and Mons, Belgium. The course is supported by The Belgian Atherosclerosis Society / Lipid Club (BAS / BLC) and the Royal Belgian Society of Clinical Chemistry (RBSCC). Further information about the program here.

Biosfer Teslab will be in the exhibition ‘Ahir, avui, demà, Catalunya Emprèn. Idees que mouen Catalunya’

Biosfer Teslab will be represented as an entrepreneur company in the exhibition ‘Ahir, avui, demà, Catalunya Emprèn. Idees que mouen Catalunya’. This exhibition will be at the 4 Catalan capitals: In Tarragona from 07/21/14 until 08/31/14 In Barcelona from 10/06/14 until 09/11/14 In Girona from 11/17/14 until 13/12/14 In Lleida from 19/12/14 until 01/10/15 In this… Read More »Biosfer Teslab will be in the exhibition ‘Ahir, avui, demà, Catalunya Emprèn. Idees que mouen Catalunya’

Carolina Sánchez joins Biosfer Teslab

The Selection Committee of the “Santander Scholarships CRUE CEPYME Internship” has allocated a grant to Carolina Sánchez, a student of the Bachelor of Business Administration at the Rovira i Virgili University, to perform an internship at Biosfer Teslab for a period of three months.